AKT1 and cancer: Protein kinase B (PKB), also known as AKT, is a major downstream effector of PI3K and one of the main perpetrators associated with the resistance to various anti-cancer agents, including cisplatin, paclitaxel, etoposide, RTKs inhibitors, as well as radiation [70,71,72,73,74].